Smart Inhalers Market Overview
Market Research Future (MRFR) has announced a new release on the global smart inhaler market. The smart inhaler market is analyzed in all its intricacy in the report, which includes a detailed analysis of the historical growth trajectory of the market as well as an analysis of the market’s key growth drivers and restraints. The global smart inhaler market is expected to exhibit a CAGR of 42.8% over the forecast period from 2016 to 2022, rising to a valuation of USD 1,636.1 million.
Smart inhalers are respiratory inhalers equipped with Bluetooth connectivity, which allows for accurate tracking of the inhaler’s usage through a smartphone app. The sensor attached to the smart inhaler keeps track of the dosage volume and timing, which allows it to provide alerts for the next dose. Smart inhalers thus allow patients to stick to their medication schedule and gain its full range of benefits. A notable problem with asthma treatment and management is that many patients fail to stick to their designated treatment schedules, leading to unnecessary and entirely avoidable complications. Smart inhalers are a key step in overcoming this problem and enabling comprehensive monitoring of asthma patients.
Browse Full Report with TOC at: https://www.marketresearchfuture.com/reports/smart-inhalers-market-2117
The growing prevalence of asthma and COPD is likely to be the key driver for the global smart inhaler market over the forecast period. Asthma is becoming increasingly prevalent in the developing as well as developed world, which has led to significant allotment of resources towards its effective management. The increasing popularity of smoking is responsible for the growing prevalence of COPD. This is likely to be the major driver for the smart inhalers market over the forecast period. The increasing support to advanced research into medical devices and technology is likely to be a key driver for the global smart inhaler market over the forecast period.
Smart Inhalers Market Segmentation:
The global smart inhalers market is segmented on the basis of type, end use, and application.
On the basis of type, the global smart inhaler market is segmented into dry powder inhalers and metered dose inhalers. Dry powder inhalers are likely to retain the majority share in the global smart inhalers market over the forecast period.
By end use, the global smart inhalers market is segmented into hospitals & clinics, respiratory care centers, and others.
By application, the smart inhalers market is segmented into asthma, COPD, and others.
Smart Inhalers Market Regional Analysis:
North America is likely to remain the majority contributor to the global smart inhalers market over the forecast period. North America holds a share of 54.3% in the global smart inhalers market and is expected to rise to a valuation of USD 888.4 million by the end of the forecast period in 2022. North America is home to many of the leading players in the smart inhalers market, which has led to steady technological progression in the design and utility of smart inhalers. The ease of obtaining smart inhalers is likely to be a major driver for the smart inhalers market in North America, as patients in underdeveloped regions such as Asia Pacific and the Middle East often find it too expensive or difficult to obtain smart inhalers. The growing prevalence of COPD in North America is likely to be a major driver for the smart inhalers market in the region over the forecast period.
Asia Pacific follows Europe in third place in the global smart inhalers market and is likely to exhibit the fastest growth of all over the forecast period due to the rapid increase in the prevalence of asthma and the rapid advancement in the healthcare sector in the region. The increasing disposable income of consumers in the region has also helped bring the smart inhalers market into the mainstream, although more work needs to be done to make smart inhalers as common as in North America or Europe. The Asia Pacific market for smart inhalers is expected to exhibit a robust 55.3% CAGR over the forecast period from 2016 to 2022.
Smart Inhalers Market Competitive Analysis:
Leading players in the global smart inhalers market include Adherium, Cohero Health, Gecko Health Innovations Inc., Propeller Health, Inspiro Medical, GSK, and AstraZeneca.
Smart Inhalers Industry Updates:
In January 2019, Teva Pharmaceutical Industries received FDA approval for a new digital inhaler product, called ProAir Digihaler.
In December 2018, Israeli inhaler maker Syqe Medical raised funding of more than USD 50 million.
